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Abstract
Background—The incidence of Clostridium difficile infection (CDI) has been increasing.
Previous studies report that the number of colectomies for CDI is also rising. Outside of a few
notable outbreaks, there are few published data documenting increasing severity of CDI. The
specific aims of this multiyear, multicenter study were to assess CDI-related colectomy rates and
compare CDI-related colectomy rates by CDI surveillance definition.
Methods—Cases of CDI and patients who underwent colectomy were identified electronically
from 5 US tertiary-care centers from July 2000 through June 2006. Chart review was performed to
determine if a colectomy was for CDI. Monthly CDI-related colectomy rates were calculated as
the number of CDI-related colectomies per 1,000 CDI cases. Data between observational groups
were compared using χ2 and Mann-Whitney U tests. Logistic regression was performed to
evaluate risk factors for CDI-related colectomy.
Results—8569 cases of CDI were identified and 75 patients had CDI-related colectomy. The
overall colectomy rate was 8.7/1,000 CDI cases. The CDI-related colectomy rate ranged from 0 to
23 per 1,000 CDI episodes across hospitals. The colectomy rates for healthcare facility (HCF)-
onset CDI was 4.3/1000 CDI cases and 16.5 /1000 CDI cases for community-onset CDI (p <.05).
There were significantly more CDI-related colectomies at hospitals B and C (p<.05).
Conclusions—The overall CDI-related colectomy rate was low, and there was no significant
change in the CDI-related colectomy rate over time. Onset of disease outside of the study hospital
was an independent risk factor for colectomy.
Introduction
Clostridium difficile infection (CDI) is one of the most common health-care associated
infections, causing significant morbidity and mortality, increased healthcare costs, and
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prolonged hospital lengths-of-stay [1–3]. Previously published reports indicate that the
incidence and severity of CDI are increasing [4–6]. The emergence of a hypervirulent,
epidemic strain and community-acquired disease in patients who were previously considered
to be low risk will likely contribute an even greater burden on patients and the healthcare
system [7–9].
Subtotal colectomy with end ileostomy is the treatment of choice for patients with fulminant
CDI refractory to medical therapy [10–15]. Studies have identified a variety of factors
associated with improved survival after CDI-related colectomy, and colectomy performed
earlier in the course of fulminant colitis, before the patient becomes critically ill, is generally
associated with improved survival [10–11, 13, 15–18]. Prior studies have reported
colectomy rates for C. difficile infection from <1–3% of CDI cases [9, 11, 14–20], and the
rate of colectomies for severe disease appears to be rising over time [21]. These studies have
been limited to single-centers or outbreak settings, so little is known about overall temporal
trends in colectomy rates in non-outbreak settings. Furthermore, the relationship between the
location of CDI symptom onset and the risk for colectomy for CDI is unknown.
The objective of this study was to conduct a multicenter, multiyear analysis of the incidence
of colectomies for severe CDI in a non-outbreak setting. Colectomy cases were further
classified by the location of CDI onset, using published recommended surveillance
definitions.
METHODS
Setting and Population
Five geographically diverse academic hospitals participating in the Prevention Epicenters
Program of the Centers for Disease Control and Prevention collected inpatient data from
July 1, 2000, through June 30, 2006. These hospitals were Barnes-Jewish Hospital (Saint
Louis, Missouri), Brigham and Women’s Hospital (Boston, Massachusetts), the Ohio State
University Medical Center (Columbus, Ohio), Stroger Hospital of Cook County (Chicago,
Illinois), and University of Utah Hospital (Salt Lake City, Utah). Notably, a prior study
found that the rates of CDI were significantly different between the hospitals, but there were
no sustained outbreaks [4]. Inpatients > 18 years old were included in the study. Electronic
medical records were queried to retrospectively collect dates of positive C. difficile toxin
assay results, demographic information, comorbid conditions, International Classification of
Diseases ninth revision clinical modification (ICD-9-CM) diagnosis codes, ICD-9-CM
procedure codes for colectomy or hemicolectomy (45.73, 45.75, 45.76, 45.79, 45.8), and
admission and discharge dates. In order to provide a description of the overall population at
the five hospitals, four patients not diagnosed with CDI were randomly selected among the
patients discharged from the same study hospital during the same year for every case of CDI
identified by toxin assay results or ICD-9-CM codes.
Definitions
The charts of all patients with a positive assay for C. difficile or the ICD-9-CM diagnosis
code for CDI and an ICD-9-CM procedure code of colectomy were reviewed to determine if
the colectomy was for CDI (CDI-related colectomy). For patients without a colectomy, a
case of CDI was defined as a positive C. difficile stool toxin assay. For patients with CDI-
related colectomy, a case of CDI was defined as the presence of a positive C. difficile toxin
assay or the presence of the ICD-9-CM code for CDI and a CDI-related colectomy. The
reason to have different definitions for a case of CDI based on whether there was a
colectomy for CDI is two-fold. All study hospitals are academic medical centers. Patients
may be transferred for severe CDI and proceed to colectomy without repeating a toxin assay.
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In addition, patients with fulminant CDI may have an ileus or be taken to surgery prior to
obtaining stool for C. difficile testing. Therefore it was determined that charts of patients
assigned the ICD-9-CM code for CDI and a procedure code for colectomy would be
reviewed. Conversely, most patients assigned the ICD-9-CM code for CDI without a
positive toxin assay do not have CDI based on further chart review [22]. Because of this, it
was determined to be unnecessary to review the charts of the approximately 3,000 patients
assigned the ICD-9-CM code for CDI but who did not have a positive toxin assay or a
colectomy.
Cases of CDI were categorized based on previously published surveillance definitions [4,
23–25]. Charts of all patients with CDI onset ≤ 48 hours from admission were reviewed to
determine recent healthcare exposures. Cases were categorized as healthcare facility (HCF)
onset; community-onset, study hospital associated; community-onset, non-study HCF
associated; indeterminate; and recurrent (Table 1). Recurrent cases were cases of CDI with a
history of a positive toxin assay within the previous 8 weeks.
Data Analysis
Colectomy rates were calculated as the number of CDI-related colectomies per 1,000 toxin-
positive cases. Data from hospital E were incomplete for the first 14 months; these months
for hospital E were excluded from the analysis. Composite Charlson scores were calculated
to assess comorbidity [26]. All tests were 2-tailed, and a P value of less than 0.05 was
considered statistically significant, with Bonferroni adjustments for multiple comparisons
when applicable. Data were compared with χ2, χ2 for trend, Fisher exact tests, and Mann-
Whitney U tests. Univariate logistic regression was used to examine the contributions of
age, sex, race, location of onset, Charlson score, and study center to the risk of colectomy.
Variables associated with colectomy in unadjusted analysis (p<.05) were included in a
multivariable regression logistic model to identify independent predictors of colectomy.
Stepwise, backwards logistic regression was used for multivariate analysis. Variables with
significance levels p <0.05 were retained in the final model. Odds ratios (OR) with 95%
confidence intervals (95% CI) were calculated for each variable. The data were analyzed
using Epi-Info, version 3.4 (Centers for Disease Control and Prevention, Atlanta, GA), and
SPSS for Windows, version 17.0 (SPSS Inc., Chicago, IL). Approval was obtained from the
institutional review boards of the Centers for Disease Control and Prevention and at each of
the participating centers.
RESULTS
During the study period there were 8569 episodes of toxin positive CDI in 8033 patients,
including 540 (6.3%) cases of recurrent CDI. There were 252 patients with a positive toxin
assay or who were assigned the ICD-9-CM code for CDI and underwent a colectomy during
the same hospitalization. Seventy-five (29.8%) of these patients had a CDI-related
colectomy. Forty-nine patients (65%) with CDI-related colectomy had a documented
positive toxin assay during the same admission. The colectomy incidence over the entire
study period was 8.7 CDI-related colectomies per 1000 CDI episodes. There was no
significant overall trend in the annual incidence of CDI-related colectomy during the study
period.
Demographic data are provided in Table 2. Overall, patients with CDI were older (p<.05)
and had higher Charlson scores than patients without CDI (p<.05). The median age of
patients who had a CDI-related colectomy was higher than patients with CDI who did not
have a colectomy (68.2 years versus 61.5 years, p=.03). White patients made up 71% of
toxin-positive CDI cases, but 83% of patients who had a CDI-related colectomy (p=.03).
The proportion of colectomy patients who were female was 43%, compared to 50% of
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patients with a CDI-related colectomy (p=.23). The population of patients who underwent a
CDI-related colectomy had lower mean Charlson scores compared to patients with CDI who
did not undergo colectomy (p=.04).
Colectomy incidence at each hospital during the study period ranged from 0 to 23 per 1,000
CDI episodes. The only hospital with a significant linear trend in the annual colectomy rate
over time was hospital A, with an increase in CDI-related colectomy during the study period
(p=.01) (Figure 1). Though annual variations were evident, particularly at hospital C and D,
there were likely too few colectomies to find a significant linear trend. No colectomies for
CDI were reported at hospital E during the study period. Comparisons by study center are
presented in Table 2. Among patients without CDI, those at hospital A were the oldest and
those at hospital B were the youngest (55 years versus 47 years, p<.001). Patients at hospital
C had the highest Charlson comorbidity scores; patients at hospital E had the lowest (1.6
versus 0.5, p<.001). Among patients with CDI who did not undergo colectomy, those at
hospital C were the oldest (66 years) and had the highest mean Charlson scores (2.5), while
those at hospital E were the youngest (51 years) and had the lowest Charlson scores (0.7)
(both p<.001). Patients with CDI-related colectomy were the oldest (70 years) at hospital D
and the youngest at hospital B (42 years) (p=.02, not significant after Bonferroni correction).
Those who had CDI-related colectomy at hospital D had the lowest Charlson scores, and
those at hospital C had the highest scores (0.6 versus 2.2, p=.01).
HCF-onset CDI represented 4897 episodes of CDI (58% of all toxin-positive episodes)
(Table 3). There were 21 CDI-related colectomies for HCF-onset CDI, accounting for 29%
of all CDI-related colectomies. There were 794 episodes of community-onset, study hospital
associated CDI (9% of all episodes) and 10 CDI-related colectomies (13% of CDI-related
colectomy). The community-onset, non-study hospital HCF associated category includes
1063 episodes of CDI (12% of all episodes) and 23 CDI-related colectomies (31% of CDI-
related colectomies). There were 520 episodes of community-associated CDI (6% of all
episodes) and 5 CDI-related colectomies (7% of CDI-related colectomies). Community-
onset cases had higher colectomy rates than hospital-onset cases at all four hospitals that
reported colectomies during the study period (Figure 2). Six percent of cases and four
percent of colectomies were patients with recurrent CDI.
Risk factors for CDI-related colectomy are presented in Table 4. Advanced age (65 years
and older) was associated with an odds ratio of 1.9 for colectomy (p<.05). White patients
had a significantly higher odds ratio for colectomy compared to non-white patients (OR 2.0,
p=.02). Admission to hospitals C and D was also associated with more CDI-related
colectomies (p<.05). There were no differences in the risk of colectomy by patient gender,
discharge year, or Charlson score. After multivariable adjustment, age 65 years or older (OR
1.6, 95% CI 1.0–2.6), admission to hospital C (OR 4.0 95% CI 2.3–7.0) or D (OR 2.4 95%
CI 1.3–4.5), and community-onset CDI (OR 3.4, 95% CI 2.0–5.5) remained significantly
associated with CDI-related colectomy.
DISCUSSION
This study examined CDI-related colectomy rates at multiple healthcare facilities over a six
year time period. We also assessed risk factors associated with CDI-related colectomy. Prior
studies of colectomy for CDI were limited by being conducted at single-centers, over
relatively brief periods of time, or in response to CDI outbreaks. These studies have
potentially biased the literature to more severe outbreaks of CDI. Our study minimizes these
biases by including multiple healthcare facilities over several years in the absence of any
sudden increases in CDI incidence or clinically apparent increases in deaths due to CDI [4].
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CDI-related colectomy rates in the literature differ based on the clinical setting, drawing
from a wide variety of patient populations and CDI rates. The overall CDI-related colectomy
rate in this study was 8.7/1,000 CDI cases, which is consistent with previously published
rates, ranging from 2.7 to 32 colectomies per 1,000 CDI cases [9, 11, 14–20]. Kutty et al
(2010) recently published a report of a community-based CDI outbreak in 6 hospitals in
North Carolina involving 109 patients with CDI; none required ICU admission or a
colectomy [9]. It was hypothesized that the paucity of severe cases was due to the young age
of the study population (median age of 62 years). In contrast, Lamontagne et al (2007) found
that 23% of the 165 patients in 2 hospitals’ ICUs with fulminant colitis required a colectomy
[13]. The hospitalized population in our study includes low and high acuity patients, and the
colectomy rate fell between those two extremes.
There are few published data describing colectomy rates according to CDI surveillance
definitions. One single-center study during an outbreak at a community hospital reported a
colectomy incidence for healthcare facility onset CDI of 2% [19]. The HCF-onset colectomy
rate in our study was lower, at 0.43%. We found that patients who had community-onset
CDI with recent HCF exposure had the highest colectomy rate (Table 3). To our knowledge,
there are no prior studies on colectomy incidence in community-onset cases that can be used
for comparison. The colectomy rate in patients with community-onset CDI in this study may
be biased high. Four of the five study hospitals are academic referral centers. It is not
uncommon for patients with severe CDI to be transferred for management of severe CDI
and possible colectomy.
There are no standard guidelines for selecting patients with CDI for colectomy, and this may
account for the differences in CDI-related colectomy rates across the study hospitals. Some
patterns did emerge. Overall, patients who underwent CDI-related colectomy were
significantly older compared to patients with CDI who did not have a colectomy. This age
difference was present at all centers, and likely reflects the higher likelihood that older
patients develop severe CDI [6, 20, 27]. Patients who had a CDI-related colectomy had
lower Charlson scores compared to patients with CDI who did not have a colectomy. This
may reflect a greater willingness to proceed to colectomy among patients with fewer
comorbidities who are more likely to survive an emergent, high-risk procedure. Patients
were more likely to have a colectomy for CDI at hospitals C and D. There were no obvious
associations between mortality of patients without CDI and patients with CDI, and CDI-
related colectomy rates. Data on treatment for CDI was not collected. Therefore it is not
possible to determine if differences in CDI-related colectomy rates translated to improved
patient outcomes.
This study has some limitations. Different case definitions were used for the numerator and
denominator to determine the rate of CDI-related colectomy. When conducting surveillance
for a rare event, missing a few cases may result in large differences in identified disease
incidence. On the other hand, missing a few non-cases has less of an impact on the identified
disease incidence. These factors must be considered when balancing the accuracy of the
method of surveillance with the resources necessary to conduct the surveillance. Using
ICD-9-CM codes to identify patients with CDI has been shown to overestimate the number
of cases of CDI, and most patients with the ICD-9-CM code for CDI without a
corresponding positive toxin assay do not have CDI. Although ICD-9-CM codes are specific
for CDI, the positive predictive value is only ~75% due to the relatively low prevalence of
CDI [22]. Therefore, it was decided to limit the CDI without colectomy group to CDI cases
with positive toxin assays only. Conversely, there was concern that some patients with CDI
diagnosed at a referring healthcare facility would be transferred for severe CDI and proceed
to colectomy without repeating a toxin assay at the study hospital, or patients with fulminant
CDI may be taken to surgery prior to procurement of a stool specimen for toxin testing.
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Although these cases represent a minority of all CDI cases, they may represent a large
proportion of patients who have a CDI-related colectomy. These patients were included in
the definition of CDI-related colectomy to avoid missing these cases. Consequently,
colectomy rates may be overestimated, particularly for community-onset, non-study hospital
associated cases. This is notable considering the overall low incidence of colectomy
identified in this study.
As reported previously [4], hospital B experienced a CDI pseudo-outbreak from July 1, 2004
to June 30, 2006 related to improper stool sample collection and transport. We chose to
include data from hospital B during the pseudo-outbreak for this particular study, since two
of the four colectomies performed during the study period at hospital B were performed
during the pseudo-outbreak. The true colectomy incidence during these periods is therefore
likely biased low. Another limitation of the data is that different toxin assays were used
among the hospitals over the study period. It is unclear how or to what extent these different
assays may have influenced CDI incidence. Additionally, data on infecting C. difficile
strains are not available. It is possible the hospitals involved in this study have a low
proportion of CDI cases due to highly-virulent, epidemic strains, thus accounting for the low
colectomy incidence. The epidemic BI / NAP1 / 027 strain has been identified at hospital A.
This study reports that no significant change in overall colectomy rates occurred from 2000
to 2006, but that CDI-related colectomy is associated with community-onset CDI, there are
differences in colectomy incidence across healthcare facilities without obvious impact on
outcomes, and CDI-related colectomy is associated with high mortality. Because of the
difficulties in establishing optimal criteria on when to take a patient with CDI to surgery, our
study supports the need for prospective surveillance studies to track CDI-related colectomy
trends in stable sentinel populations using standardized case definitions. Studies such as
these will allow for comparisons between healthcare facilities to identify trends in CDI-
related colectomies and factors associated with improved patient outcomes which can be
used to improve patient selection for CDI-related colectomy.
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Figure 1.
Colectomy rates by hospital over time. There was a significant increase in colectomies over
time at hospital A (p=.01)
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Figure 2.
CDI-related colectomy rates by location of symptom onset.
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Table 1
Definitions of Clostridium difficile Infection (CDI) According to Exposures
Type of CDI Definition
Health care facility-onset, health care facility-
associated
Patient's stool sample tested positive >48 h after admission to study hospital
Community-onset, study hospital associated Patient’s stool sample tested positive ≤48 hours after admission, provided that
symptom onset was less than 4 weeks after the last discharge from a HCF and the
most recent discharge was from an Epicenter
Community-onset, non-study hospital associated Patient’s stool sample tested positive ≤48 hours after admission, provided that
symptom onset was less than 4 weeks after the last discharge from a HCF and the
most recent discharge was from a HCF other than an Epicenter
Community-onset, community associated Patient’s stool sample tested positive ≤48 hours after admission, provided that more
than 12 weeks have elapsed since the last discharge from a HCF
Indeterminate Patient’s exposure setting does not fit any of the other criteria (e.g., positive stool
sample ≤48 hours after admission with HCF exposure 4–12 weeks prior to sample
collection)
Recurrent Patient’s stool sample tested positive ≤8 weeks after a prior positive stool sample
Unknown Patient’s exposure setting cannot be determined because of lack of available data
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Table 2
Patient Characteristics
Characteristic Patients Without
CDI
Patients With CDI1 Patients With
Colectomy for CDI
Hospital A
(n=28215)
Number of Patients 24232 3955 28
Median Age, y (range) 55.1 (18–103) 64.1 (18–105) 68.1 (23–87)
Female (%) 13727 (57) 2015 (51) 15 (54)
Non-White (%) 9075 (37) 1192 (30) 7 (25)
Mean Charlson Score (range) 1.5 (0–16) 2.2 (0–15) 1.4 (0–7)
Mortality (%) 2.8 12.7 53.6
Hospital B
(n=8313)
Number of Patients 6977 1332 4
Median Age, y (range) 47.1 (18–101) 56.2 (18–102) 42.2 (36–66)
Female (%) 4016 (58) 662 (50) 0 (0)
Non-White (%) 1315 (19) 168 (13) 0 (0)
Mean Charlson Score (range) 1.1 (0–12) 2.2 (0–14) 1.3 (0–4)
Mortality (%) 2.2 6.5 25.0
Hospital C
(n=10692)
Number of Patients 9641 1026 25
Median Age, y (range) 54.3 (18–106) 65.6 (18–97) 69.6 (42–87)
Female (%) 5612 (58) 535 (52) 11 (44)
Non-White (%) 2643 (27) 166 (16) 4 (16)
Mean Charlson Score (range) 1.6 (0–15) 2.5 (0–14) 2.2 (0–11)
Mortality (%) 3.3 8.4 28.0
Hospital D
(n=10201)
Number of Patients 9147 1036 18
Median Age, y (range) 53.9 (18–104) 63.4 (19–100) 70.1 (44–88)
Female (%) 5266 (58) 512 (49) 6 (33)
Non-White (%) 3153 (34) 231 (22) 2 (11)
Mean Charlson Score (range) 1.3 (0–15) 1.4 (0–11) 0.6 (0–3)
Mortality (%) 2.4 8.6 33.3
Hospital E
(n=4165)
Number of Patients 3530 635 0
Median Age, y (range) 49.9 (18–100) 50.6 (18–99) -
Female (%) 1691 (48) 237 (37) -
Non-White (%) 3139 (89) 552 (87) -
Mean Charlson Score (range) 0.5 (0–10) 0.7 (0–11) -
Mortality (%) 2.4 7.7 -
Overall
(n=61586)
Number of Patients 53527 7984 75
Median Age, y (range) 53.4 (18–106) 61.5 (18–105)2 68.2 (23–88)3
Female (%) 30312 (57) 3961 (50) 32 (43)
Non-White (%) 19325 (36) 2309 (29) 13 (17)
Mean Charlson Score (range) 1.4 (0–16) 2.0 (0–15)4 1.5 (0–11)5
Mortality (%) 2.7 10.2 38.7
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1Cases of recurrent CDI are excluded
2p<.05 comparing age of patients with and without CDI
3p=.03 comparing age of patients with CDI with and without colectomy
4p<.05 comparing Charlson score of patients with and without CDI
5p=0.04 comparing Charlson score of patients with CDI with and without colectomy
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